PTCL
Clinical trials for PTCL explained in plain language.
Never miss a new study
Get alerted when new PTCL trials appear
Sign up with your email to follow new studies for PTCL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New CAR-T therapy targets tough T-Cell cancers in early trial
Disease control Recruiting nowThis study tests a new treatment using specially engineered immune cells (CAR-T cells) that target a protein called CD5 on cancer cells. It is for 30 people aged 3 to 70 with T-cell acute lymphoblastic leukemia or T-cell lymphoma that has come back or not responded to standard tr…
Matched conditions: PTCL
Phase: PHASE1, PHASE2 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
New drug cocktail takes on tough lymphoma
Disease control Recruiting nowThis study tests if a combination of two drugs (oral azacytidine and romidepsin) works better than standard single drugs for people with peripheral T-cell lymphoma (PTCL) that has returned or not responded to prior therapy. About 50 adults will be randomly assigned to either the …
Matched conditions: PTCL
Phase: PHASE2 • Sponsor: University of Virginia • Aim: Disease control
Last updated May 19, 2026 11:59 UTC